| 1 |
33722775 | PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss. | 2021 Jun |
2 |
| 2 |
33108252 | Revisiting PPARγ as a new friend of GPR120 in the treatment of metabolic disorders. | 2020 Dec |
1 |
| 3 |
30594432 | Identification of BR101549 as a lead candidate of non-TZD PPARγ agonist for the treatment of type 2 diabetes: Proof-of-concept evaluation and SAR. | 2019 Feb 15 |
1 |
| 4 |
29497032 | De novo adipocyte differentiation from Pdgfrβ+ preadipocytes protects against pathologic visceral adipose expansion in obesity. | 2018 Mar 1 |
1 |
| 5 |
28193552 | Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones. | 2017 Apr |
5 |
| 6 |
27138164 | GQ-16, a TZD-Derived Partial PPARγ Agonist, Induces the Expression of Thermogenesis-Related Genes in Brown Fat and Visceral White Fat and Decreases Visceral Adiposity in Obese and Hyperglycemic Mice. | 2016 |
2 |
| 7 |
26140591 | Genetic Variation Determines PPARγ Function and Anti-diabetic Drug Response In Vivo. | 2015 Jul 2 |
1 |
| 8 |
26362846 | Rosiglitazone activation of PPARγ-dependent signaling is neuroprotective in mutant huntingtin expressing cells. | 2015 Nov 1 |
2 |
| 9 |
23650507 | Novel insulin sensitizer modulates nutrient sensing pathways and maintains β-cell phenotype in human islets. | 2013 |
1 |
| 10 |
21907283 | PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease. | 2012 Jan |
5 |
| 11 |
22215652 | Selective PPARγ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice. | 2012 Mar 1 |
1 |
| 12 |
21651979 | The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease. | 2011 Sep |
4 |
| 13 |
20668093 | Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma. | 2010 Oct 15 |
6 |
| 14 |
20829614 | Role of the PPAR-γ system in normal and tumoral pituitary corticotropic cells and adrenal cells. | 2010 |
1 |
| 15 |
19389808 | MBX-102/JNJ39659100, a novel peroxisome proliferator-activated receptor-ligand with weak transactivation activity retains antidiabetic properties in the absence of weight gain and edema. | 2009 Jul |
1 |
| 16 |
17007742 | Antidiabetic effect of a novel non-thiazolidinedione PPAR gamma/alpha agonist on ob/ob mice. | 2006 Oct |
1 |
| 17 |
15735430 | Intestinal antiinflammatory effects of thiazolidenedione peroxisome proliferator-activated receptor-gamma ligands on T helper type 1 chemokine regulation include nontranscriptional control mechanisms. | 2005 Mar |
2 |
| 18 |
16050946 | Pharmacological profile of a novel, non-TZD PPARgamma agonist. | 2005 Sep |
1 |
| 19 |
14764597 | Peroxisome proliferator-activated receptor gamma activation modulates cyclin D1 transcription via beta-catenin-independent and cAMP-response element-binding protein-dependent pathways in mouse hepatocytes. | 2004 Apr 23 |
4 |
| 20 |
9790963 | In vivo effects of pioglitazone on uncoupling protein-2 and -3 mRNA levels in skeletal muscle of hyperglycemic KK mice. | 1998 Oct 9 |
2 |